mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
2009 ◽
Vol 15
(17)
◽
pp. 5404-5413
◽
2010 ◽
Vol 9
(8)
◽
pp. 2411-2422
◽
2013 ◽
Vol 12
(7)
◽
pp. 1367-1377
◽
Keyword(s):
2000 ◽
Vol 53
(12)
◽
pp. 938-939
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 126
(3)
◽
pp. 481-490
◽
Keyword(s):